Related Experiment Videos
The effect of valproic acid on SCE and chromosome aberrations in epileptic children
Insights
Valproic acid (VPA) treatment in epileptic children significantly increases sister-chromatid exchanges (SCE) in lymphocytes. In vitro exposure also elevated SCE, suggesting VPA
Area of Science:
- Cytogenetics
- Pharmacology
- Pediatric Neurology
Background:
- Epilepsy is a common neurological disorder.
- Valproic acid (VPA) is a widely used antiepileptic drug.
- Chromosomal abnormalities and sister-chromatid exchange (SCE) are indicators of genotoxicity.
Purpose of the Study:
- To investigate the genotoxic effects of valproic acid (VPA) in epileptic children.
- To assess the impact of VPA on sister-chromatid exchange (SCE) and chromosome aberrations.
Main Methods:
- Peripheral blood lymphocytes from 20 epileptic children on VPA monotherapy and 2 control groups were analyzed for SCE and chromosome aberrations.
- SCE was also evaluated in 10 epileptic children before and after VPA treatment.
- Lymphocytes from 9 healthy children were exposed in vitro to VPA.
Main Results:
- Significantly higher SCE frequencies were observed in VPA-treated epileptic children compared to controls (p < 0.01).
- A statistically significant increase in SCE was noted after VPA treatment in epileptic children.
- In vitro exposure of lymphocytes to VPA resulted in a significant increase in SCE.
Conclusions:
- Valproic acid (VPA) demonstrates a genotoxic potential, evidenced by increased sister-chromatid exchange (SCE) in lymphocytes.
- The findings suggest that VPA may induce chromosomal instability.
- Further research is warranted to fully understand the long-term implications of VPA-induced genotoxicity.
Abstract:
Sister-chromatid exchange (SCE) and chromosome aberrations have been studied in peripheral lymphocytes of 20 epileptic children treated in monotherapy with valproic acid (VPA) for 6-52 months and in 2 matched control groups. The frequencies of SCE in the VPA-treated epileptic children were significantly higher than in the 2 control groups (p less than 0.01); rates of chromosome aberrations were slightly higher but not significantly different from the 2 control groups. We also examined SCE in 10 epileptic children before and after they took sodium valproate for 6-7 months; there was a statistically significant change in SCE following VPA. 9 normal children whose lymphocytes were exposed in vitro to sodium valproate (5-20 micrograms/ml) showed a significant increase in SCE.